Correlation Between BC IRON and Heidelberg Pharma

Can any of the company-specific risk be diversified away by investing in both BC IRON and Heidelberg Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining BC IRON and Heidelberg Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between BC IRON and Heidelberg Pharma AG, you can compare the effects of market volatilities on BC IRON and Heidelberg Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in BC IRON with a short position of Heidelberg Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of BC IRON and Heidelberg Pharma.

Diversification Opportunities for BC IRON and Heidelberg Pharma

-0.47

Correlation Coefficient

BC IRON  Heidelberg Pharma

Very good diversification

The 3 months correlation between BC3 and Heidelberg is -0.47. Overlapping area represents the amount of risk that can be diversified away by holding BC IRON and Heidelberg Pharma AG in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Heidelberg Pharma and BC IRON is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on BC IRON are associated (or correlated) with Heidelberg Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Heidelberg Pharma has no effect on the direction of BC IRON i.e., BC IRON and Heidelberg Pharma go up and down completely randomly.

Pair Corralation between BC IRON and Heidelberg Pharma

Assuming the 90 days trading horizon BC IRON is expected to under-perform the Heidelberg Pharma. But the stock apears to be less risky and, when comparing its historical volatility, BC IRON is 1.24 times less risky than Heidelberg Pharma. The stock trades about -0.09 of its potential returns per unit of risk. The Heidelberg Pharma AG is currently generating about 0.06 of returns per unit of risk over similar time horizon. If you would invest  235.00  in Heidelberg Pharma AG on December 23, 2024 and sell it today you would earn a total of  22.00  from holding Heidelberg Pharma AG or generate 9.36% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	98.36%
Values	Daily Returns

BC IRON  vs.  Heidelberg Pharma AG

BC IRON

Risk-Adjusted Performance

Very Weak

Over the last 90 days BC IRON has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unsteady performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in April 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Heidelberg Pharma

Risk-Adjusted Performance

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Heidelberg Pharma AG are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively fragile basic indicators, Heidelberg Pharma may actually be approaching a critical reversion point that can send shares even higher in April 2025.

Pair Trading with BC IRON and Heidelberg Pharma

The main advantage of trading using opposite BC IRON and Heidelberg Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if BC IRON position performs unexpectedly, Heidelberg Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Heidelberg Pharma will offset losses from the drop in Heidelberg Pharma's long position.

The idea behind BC IRON and Heidelberg Pharma AG pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..